What are the Challenges in Using LMWH in Neonates?
Some of the challenges in using LMWH in neonates include the lack of standardized dosing guidelines, the need for frequent monitoring, and the difficulty in obtaining accurate anti-Xa levels. Additionally, the pharmacokinetics of LMWH can vary significantly among neonates, particularly those with renal impairment or other comorbidities.
